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Abstract
Background: Fetal cardiovascular magnetic resonance (CMR) imaging may provide a valuable adjunct to fetal
echocardiography in the evaluation of congenital cardiovascular pathologies. However, dynamic fetal CMR is
difficult due to the lack of direct in-utero cardiac gating. The aim of this study was to investigate the effectiveness
of a newly developed Doppler ultrasound (DUS) device in humans for fetal CMR gating.
Methods: Fifteen fetuses (gestational age 30–39 weeks) were examined using 1.5 T CMR scanners at three different
imaging sites. A newly developed CMR-compatible DUS device was used to generate gating signals from fetal
cardiac motion. Gated dynamic balanced steady-state free precession images were acquired in 4-chamber and
short-axis cardiac views. Gating signals during data acquisition were analyzed with respect to trigger variability
and sensitivity. Image quality was assessed by measuring endocardial blurring (EB) and by image evaluation
using a 4-point scale. Left ventricular (LV) volumetry was performed using the single-plane ellipsoid model.
Results: Gating signals from the fetal heart were detected with a variability of 26 ± 22 ms and a sensitivity of
trigger detection of 96 ± 4%. EB was 2.9 ± 0.6 pixels (4-chamber) and 2.5 ± 0.1 pixels (short axis). Image quality
scores were 3.6 ± 0.6 (overall), 3.4 ± 0.7 (mitral valve), 3.4 ± 0.7 (foramen ovale), 3.6 ± 0.7 (atrial septum), 3.7 ± 0.5
(papillary muscles), 3.8 ± 0.4 (differentiation myocardium/lumen), 3.7 ± 0.5 (differentiation myocardium/lung),
and 3.9 ± 0.4 (systolic myocardial thickening). Inter-observer agreement for the scores was moderate to very
good (kappa 0.57–0.84) for all structures. LV volumetry revealed mean values of 2.8 ± 1.2 ml (end-diastolic
volume), 0.9 ± 0.4 ml (end systolic volume), 1.9 ± 0.8 ml (stroke volume), and 69.1 ± 8.4% (ejection fraction).
Conclusion: High-quality dynamic fetal CMR was successfully performed using a newly developed DUS device
for direct fetal cardiac gating. This technique has the potential to improve the utility of fetal CMR in the evaluation of
congenital pathologies.
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Background
Fetal magnetic resonance imaging is an increasingly used
diagnostic tool for evaluation of the fetal central nervous
system, thorax, and abdomen [1–3]. In contrast to other
organ systems, a comprehensive assessment of the fetal
cardiovascular system requires dynamic imaging to resolve
cardiac motion and blood flow. However, the clinical ap-
plication of fetal cardiovascular magnetic resonance
(CMR) imaging lags behind due to technical challenges
[4]. The main challenge is the lack of a cardiac gating sig-
nal that synchronizes image data acquisition to the cardiac
cycle and builds images over multiple cardiac cycles to
optimize temporospatial resolution. Cardiac gating is the
main technique used post-natally for dynamic CMR and
utilizes the patient’s surface electrocardiogram (ECG) sig-
nal to track the cardiac cycle. The fetal ECG signal, how-
ever, cannot be obtained in-utero during CMR.
Doppler ultrasound (DUS) is a well-established tech-
nique that allows real-time assessment of the fetal heart
rate [5]. As DUS is theoretically not influenced by the
electromagnetic field of the CMR scanner [6, 7], it pro-
vides an opportunity to synchronize CMR data acquisition
with the fetal cardiac cycle. The recent innovation of a
CMR compatible DUS transducer demonstrated promis-
ing results to overcome the shortcomings of fetal cardiac
gating. The DUS gating technique was applied for cardiac
cine imaging in healthy adult human volunteers, revealing
excellent agreement of quantitative and qualitative param-
eters compared to ECG and pulse oximetry gating
methods [8, 9]. Initial trials demonstrated the potential of
the DUS transducer for gating also of the fetal heart per-
forming cardiac cine imaging and phase-contrast CMR
angiography in sheep fetuses [10, 11]. However, the trans-
fer of this gating method to human fetuses is associated
with different imaging conditions. Unlike the previous
feasibility studies in sedated and intubated animals and
healthy adult humans, CMR imaging of pregnant women
is much more challenging. Examination time may be lim-
ited due to comfort reasons of the pregnant women, and
breath-hold duration may also be limited due to preg-
nancy. The human fetus is also more likely to move dur-
ing the scan as compared with fetuses in sedated animal.
Fetal cardiac gating using an external gating device has
not yet been evaluated in human fetuses. Therefore, the
aim of this study was to investigate the effectiveness of a
newly developed CMR compatible DUS device for cardiac
gating in the human fetus.
Methods
Study subjects
The CMR compatible DUS device was evaluated prospect-
ively at three centers: University Medical Center Hamburg-
Eppendorf, Hamburg, Germany; Boston Children’s
Hospital, Boston, Massachusetts, United States; and
Lund University Hospital, Scania, Sweden. A total of 15
pregnant women at 30–39 weeks gestation participated in
the study. Five of them were enrolled following fetal ultra-
sound that raised concern for congenital malformation.
The remaining 10 subjects were recruited as part of a
multi-center study of fetal CMR. The study was approved
by the respective local ethic committees, and written
informed consent was obtained from all participants.
Cardiac gating
A newly developed DUS device was used for external fetal
cardiac gating (northh medical GmbH, Hamburg,
Germany) following the principles as previously described
for cardiac gating of the adult heart (Fig. 1a) [9]. A com-
mercially available DUS transducer (HP 15245A, Hewlett
Packard, Palo Alto, California, USA) was made CMR com-
patible by replacing all magnetic components with non-
magnetic materials. The DUS device was designed to trans-
mit 1.024 MHz ultrasound pulses at a repetition frequency
of 3.2 kHz and an acoustic intensity of 4.6 mW/cm2 to the
connected DUS transducer inside the CMR bore. The DUS
transducer was connected to the DUS device using a 7 m
long transmission line. Electromagnetic interferences be-
tween the radiofrequency (RF) field of the CMR scanner
and the transmission line were minimized by using four
cable traps located 30 cm apart and tuned to 64 MHz [12].
The DUS signal received by the transducer is mainly based
on fetal cardiac wall motion [13]. The less prominent effect
of blood flow was neglected by low-pass filtering with a
cut-off frequency of 100 Hz. The recorded signal (0–10 Hz)
from the DUS transducer underwent peak detection ana-
lysis implemented on a microcontroller (STM32F4, STMi-
croelectronics, Geneva, Switzerland) that was part of the
DUS device, processing data in real time. The resulting fetal
cardiac DUS signal used for trigger detection is shown in
Fig. 1b. Dedicated software estimated the RR interval by
autocorrelation of the first 1.250 ms of the recorded signal
as previously described [9]. A shiftable cover window refer-
ring to the estimated RR interval and previous detected
trigger time points enabled calculation of the next expected
trigger time point and hence allowed exclusion of peaks re-
lated to motion during myocardial relaxation. To provide a
cardiac gating signal for the MR scanner, the external input
terminal for gating signals was used which requires a
normed Transistor-transistor-logic (TTL) signal. A stand-
ard Bayonet Neill Concelman (BNC) connection was used
to transfer the calculated gating signals from the DUS de-
vice to the external input terminal of the CMR scanner.
The generated DUS gating signals were stored for each
fetus to assess parameters such as heart rate variability
and sensitivity of trigger signal detection. The sensitivity
of trigger signal detection was calculated using visually
defined fetal heart beats from the original DUS signal as
an external reference.
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Image acquisition
All scans were performed on clinical 1.5 T CMR
scanners (Philips Achieva, Best, the Netherlands at
University Medical Center Hamburg-Eppendorf and
Boston Children’s Hospital; Siemens Avanto, Siemens
Healthineers, Erlangen, Germany at Lund University
Hospital) using a multichannel cardiac coil. Examina-
tions were performed with the subjects in a left decu-
bital or supine position. First, the position of the
fetus was palpated. Subsequently, the DUS transducer
was moved over the lower maternal abdomen above
the fetal thorax until a constant fetal cardiac signal
was recorded. The transducer was then held in pos-
ition by an elastic belt around the maternal abdomen.
The coil was placed external to the transducer.
Real-time interactive balanced steady-state free pre-
cession (bSSFP) imaging was used to plan cardiac im-
aging planes. Using the fetal cardiac gating signal
from the DUS device, retrospectively gated bSSFP
cine imaging (Table 1) was performed in cardiac 4-
chamber and short-axis views during maternal breath-
hold.
The DUS signal and the corresponding gating signal
were stored during CMR image acquisition and later
evaluated to determine the quality of the gating signal in
terms of heart rate variability and sensitivity to detect
each heartbeat.
Image analysis
Qualitative analysis consisted of independent image
quality ratings by two radiologists (7 and 12 years CMR
experience). The evaluation process included two differ-
ent aspects: 1) overall image quality and 2) cardiac diag-
nostic quality by structure visualization. The grading
system was based on a 4-point scale [14].
Overall image quality: 1 = low quality and/or high de-
gree of artifacts, 2 =moderate quality and/or some arti-
facts, 3 = high quality and/or few artifacts, 4 = high
quality and no artifacts.
Cardiac diagnostic quality: 1 = inadequate, 2 = low, 3 =
moderate, 4 = high.
The basis for evaluation of diagnostic quality included
discernible epi- and endocardial borders to surrounding
fetal lung and ventricular lumen, respectively, visualized
Fig. 1 Doppler Ultrasound Trigger Device. a Schematic illustration of the experimental setup during fetal CMR showing placement of the
Doppler ultrasound (DUS) transducer (*) on the maternal abdomen. The connecting cable has four traps (**) to avoid electromagnetic
interferences from radiofrequency pulses. b Example of generated DUS gating signals represented by maximum signal peaks. The fetal
heart beat was recorded by the DUS transducer and processed to allow for maximum peak detection
Table 1 Scan parameters of DUS-gated balanced SSFP cine sequences at different imaging sites
University Medical
Center Hamburg-Eppendorf
Boston Children’s Hospital Lund University Hospital
TR/TE [ms] 3.3 / 1.6 3 / 2 37 / 1.4
Flip Angle [°] 60 60 56
Parallel Reduction Factor 2 1.5 2
Heart Phases 20 20 30
Temporal Resolution [ms] 24 20 14
FOV [mm] 300 × 300 280 × 280 329 × 360
Matrix Size 288 × 288 320 × 320 234 × 256
Pixel Spacing [mm] 1.04 × 1.04 0.87 × 0.87 1.4 × 1.4
Number of Slices 1 1 1
SliceThickness [mm] 5 4 4
Scan Length [s] 8 8 9
FOV field of view, TE echo time, TR repetition time
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papillary muscles / trabeculation, delineation of the atrial
septum and the foramen ovale, and visualized myocardial
wall thickening during contraction in the 4-chamber view.
Quantitative analysis of DUS-gated images was
assessed using the edge contrast between myocardium
and lumen [15]. This method uses the edge spread func-
tion of myocardial and ventricular signal intensities and
allows calculation of endocardial border sharpness
(EBS). The edge spread function describes the contrast
of an image in terms of the gradual transition (i.e. from
black over gray to white), averaging all pixels in the ver-
tical direction and parallel to the edge [16]. For optimal
image contrast two pixels with different signals are re-
quired, where the slope of the edge spread function
would be equal to one. Inaccurate synchronization of
the cardiac cycle is the major cause for image blurring,
resulting in a decreased slope of the edge spread func-
tion, and higher number of pixels, respectively. To assess
an EBS impaired by motion blurring the slope of the
edge spread function between myocardium and lumen
was calculated as
EBS ¼ max dS rð Þ
dr
 
where S(r) is the edge spread function. Prior to calcu-
lation, S(r) was normalized using the mean lumen signal
intensities and a baseline corrected by subtracting S(r)
from the mean myocardial signal intensities. Hence, 1/
EBS determines the width of pixels between mean myo-
cardial signal intensities and lumen, describing endocar-
dial blurring (EB). An EB value of 2 (pixels) is the
theoretical optimum image contrast to differentiate the
myocardium from the lumen, whereas higher values re-
flect increased motion artifacts and hence image blur-
ring. EB was calculated in a slice perpendicular to the
mid-ventricular myocardium for the 4-chamber and
short-axis views, respectively, using a dedicated algo-
rithm in Matlab (The Mathworks, Natick, Massachu-
setts, USA). For analysis in short-axis views, the
ventricle was segmented into 36 radial sections. EB was
then calculated for each heart phase and section over a
whole RR interval. End-systolic and end-diastolic EB
were calculated as specific time points.
Quantitative analysis also included left ventricular
(LV) volumetric data and measurements of the myo-
cardial wall thickness in end-diastole. LV volumetry
was calculated using the single plane ellipsoid model
[(8 x A2 / (3 x π x L)], where A is the LV 4-chamber
area and L the long-axis length (mitral valve plane to
the apex) in the 4-chamber view.
All quantitative measurements were assessed by the
same observers as above. LV end-diastolic volume
(EDV), end-systolic volume (ESV), stroke volume (SV)
and ejection fraction (EF) were determined by manual
delineation of the endocardial border and the mitral
valve plane in end-diastolic and end-systolic 4-chamber
views using a dedicated DICOM viewer software (OsiriX
Lite, Pixmeo, Bernex, Switzerland).
Statistical analysis
Numerical data are given as mean (± standard deviation,
SD). Differences between groups were analyzed using
Students t-test with significant differences defined by
p < 0.05. Quantitative cardiac measurements were com-
pared between two observers by Bland-Altman plots
using a statistical EXCEL add-on software package
(Analyze-it Software, Ltd., Leeds, UK) within 95% limits
of agreement. A linearly weighted 4 × 2 Kappa test was
used to assess the inter-observer agreement for image
quality scores.
Results
Examination yield
Among the 15 subjects who underwent DUS gated fetal
CMR, 4-chamber views were obtained in all and short-
axis views were obtained in 11. In the remaining 4 cases,
the CMR examination was terminated because of patient
discomfort related to the small confines of the scanner
bore. No subject reported discomfort in the region of
the DUS transducer.
DUS signal quality
In all cases the DUS device produced a fetal cardiac mo-
tion signal. In four cases, the signal was lost during the
examination and was regained with repositioning the
DUS transducer; this transient loss of signal was attrib-
uted to major fetal movement based on review of the lo-
calizing images. In some cases, there was loss of the
DUS gating signal when the patient held her breath for
imaging acquisition; the signal returned when breath-
holding was completed. Loss of the DUS gating signal
may occur if the fetal heart moves out of the acoustic
window of the DUS transducer. This may be caused by
deep maternal inspiration which can result in movement
of the maternal abdominal organs, and also the fetus. In
such cases, the women were asked to use a shallower in-
spiration for breath-holding, solving the issue. In 7 cases
where the examination also included other fetal CMR
imaging, efficient scanning without need of repositioning
the DUS transducer was up to 45 min. No distortion of
the DUS gating signal from electromagnetic interfer-
ences was observed during image acquisition. Fetal heart
rates varied within normal ranges (130 to 163 bpm).
Analysis of the DUS gating signal during CMR image
acquisition resulted in a mean heart rate variability of
26 ± 22 ms. The evaluated gating signals were the sum
of gating signals used for acquisition of cine images in 4-
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chamber and short-axis views per fetus. The examin-
ation time and thus the number of evaluated gating sig-
nals per fetus varied especially due to incomplete
examinations in single fetuses as mentioned above. The
mean number of gating signals employed for all per-
formed cine acquisitions were 64 ± 21 per fetus, where 2
± 1 trigger were missed or not detected, resulting in a
mean sensitivity to detect each fetal heartbeat of 96 ±
4%. Results of the gating signal used for image acquisi-
tion are shown for each subject in Table 2.
Qualitative evaluation of overall image quality and
cardiac diagnostic quality
All fetal cardiac cine images gated with the external
DUS device could be used for analysis. Successful
fetal cardiac gating was demonstrated by clear demar-
cation of the myocardium from surrounding struc-
tures over the whole cardiac cycle for all fetuses
(Fig. 2). Overall image quality was high with no or
only few artifacts (3.6 ± 0.6). Agreement in overall
image quality between the two observers was good
(kappa = 0.67 ± 0.12).
Evaluation of cardiac diagnostic quality by structure
visualization according to the 4-point scale (1 = inad-
equate, 2 = low, 3 = moderate, 4 = high) was moderate
to high with mean values of 3.4 (± 0.7) for the mitral
valve, 3.4 (± 0.7) for the foramen ovale, 3.6 (± 0.7) for
the atrial septum, 3.7 (± 0.5) for the papillary muscles,
3.8 (± 0.4) for the differentiation of myocardium/lumen,
3.7 (± 0.5) for differentiation of myocardium/lung, and
3.9 (± 0.4) for myocardial thickening during systole.
Examples of gated 4-chamber cine images illustrating
the evaluated cardiac structures are shown in Fig. 3 and
Fig. 4. Inter-observer analysis revealed good to very
good agreement for visualization of the mitral valve,
foramen ovale, atrial septum, myocardial thickening,
and myocardium/lung interface (kappa = 0.63–0.84)
and moderate agreement for papillary muscles and
myocardium/blood interface (kappa = 0.57 and 0.58).
Table 2 DUS Gating characteristics
Subject RR Interval [ms] Variability [ms] RR Rejected Triggera Sensitivity [%]
1 461 ± 25 26 ± 22 0 72 100
2 442 ± 42 33 ± 23 3 36 92
3 445 ± 32 43 ± 29 0 82 100
4 368 ± 21 44 ± 43 4 74 95
5 394 ± 14 38 ± 28 6 86 93
6 399 ± 18 20 ± 25 3 58 95
7 428 ± 25 31 ± 21 0 25 100
8 382 ± 12 17 ± 13 1 97 99
9 388 ± 12 19 ± 15 0 34 100
10 397 ± 14 28 ± 31 0 85 100
11 400 ± 18 13 ± 12 4 71 94
12 422 ± 29 12 ± 9 2 61 97
13 446 ± 41 17 ± 24 4 90 96
14 400 ± 41 18 ± 18 2 78 97
15 454 ± 27 31 ± 32 2 76 97
Mean 418 ± 25 26 ± 22 2 ± 1 64 ± 21 97 ± 4
aNumber of trigger signals vary dependent on all acquired cine images per fetus
Fig. 2 Multiple Phases of DUS Gated Cine Images. DUS-gated
balanced SSFP cine images (20 phases) of the fetal heart in the
4-chamber view (gestational week 36). DUS gating allowed for clear
differentiation of the myocardium versus lumen throughout the
cardiac cycle. Symmetric contraction of the ventricles and expansion
of the atria is seen with maximum ventricular contraction and
minimum ventricular blood volume in cardiac phases 10–12
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Endocardial blurring and LV volumetry
Endocardial blurring (EB) due to motion was sensitive to
the cardiac cycle with different mean end-diastolic (2.4
± 0.1 pixel) and end-systolic EB (2.6 ± 0.1 pixel) (p <
0.001) (Fig. 5). Mean EB over the entire cardiac cycle
was 2.9 ± 0.6 pixel for images in 4-chamber views
assessed in 15 fetuses and 2.5 ± 0.1 pixel for images in
short axis views assessed in 11 fetuses.
Fetal LV volumetry was performed in all subjects with
LV mean values of 2.8 ± 1.2 ml (EDV), 0.9 ± 0.4 ml
(ESV), 1.9 ± 0.8 ml (SV), and 69.1 ± 8.4% (EF), respect-
ively. Myocardial wall thickness was assessed with 3.4
(± 0.5) mm.
Inter-observer variability assessed in the 15 volumetric
data sets revealed good agreement with standard devia-
tions of differences of 3.2% (bias − 0.4%; 95% limits of
agreement − 6.6% – 5.8%) for EDV, 3.3% (bias 0.2%; 95%
limits of agreement − 6.2 – 6.6%) for ESV, 5.8% (bias −
0.4%; 95% limits of agreement − 11.8 – 11%) for SV, and
2.9% (bias 0%; 95% limits of agreement − 5.7 – 5.7%) for
EF. Assessment of myocardial wall thickness in end-
diastole demonstrated similar results with standard devi-
ations of differences between single measurements of
4.5% (bias − 1.7%; 95% limits of agreement − 10.6% -
7.1%). Inter-observer variability of volumetric measure-
ments is illustrated as Bland Altman analysis (Fig. 6).
Discussion
This study demonstrates the successful application of a
newly developed DUS device for gated fetal CMR im-
aging. Dynamic CMR was performed using an external
sensor to track the fetal cardiac cycle. In this multicenter
study, dynamic cardiac-gated images were acquired in all
15 fetuses with a gestational age range of 33–39 weeks.
The DUS device caused no image artifacts and no com-
plications. Further, none of the pregnant women com-
plained about the transducer or aborted the scan due to
the device. The incomplete exams in 4 pregnant women
were due to discomfort related to the small confines of
than scanner bore. In some cases the extent of the fetal
cardiac examination was limited by loss of the DUS
Fig. 3 Example of DUS Gated Cine Image. DUS-gated bSSFP cine
image of a fetus (gestational week 34) in the end-systolic 4-chamber
view demonstrating the foramen ovale (dashed white arrow), the
atrial septum (white arrow), the mitral valve (dashed black arrow)
and the tricuspid valve (black arrow)
Fig. 4 DUS Gated Cine Image in End-Diastole and End-Systole. DUS-gated bSSFP 4-chamber cine views of a fetus (gestational week 35) in
end-diastole (left) and end-systole (right) illustrating the foramen ovale (white dashed arrow) as a discontinuity of the atrial septum (* = left ventricle).
Images demonstrate clear differentiation of the hypointense myocardium from the hyperintense ventricular blood and lung, respectively.
Myocardial thickening can be noticed in end-systolic images
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gating signal related to major fetal motion and maternal
breath-holding. Image quality was rated moderate to
high and allowed reliable identification of fetal cardiac
structures. The myocardial border sharpness was quanti-
fied by measuring EB and demonstrated good results
with a reliable assessment of volumetric data. This tech-
nique has the potential to improve the effectiveness of
fetal CMR and to yield novel information about cardiac
function and blood flow in the developing fetus.
The results of the current study demonstrate suc-
cessful application of the DUS transducer for gating
fetal CMR. The transducer was not influenced by the
CMR scanner and image quality was not affected.
The generated DUS signal used for fetal cardiac gat-
ing showed a sensitivity of 96% for cardiac cycle rec-
ognition, which is similar to reported sensitivities of
ECG gating in adults [17, 18]. Moreover, one indica-
tor for correct detection of the cardiac cycle is the
variability of the gating signal. The measured heart
rate variability of 26 ms is similar to previously re-
ported values ranging from 16 to 25 ms,.suggesting
reliable detection of each heart cycle for freezing
cardiac motion without image blurring. However, at
this point it must be mentioned that the variability of
the gating signal is rather an indicator than a quanti-
tative measure. The capability of DUS gating to freeze
cardiac motion was further quantified by determin-
ation of EB. EB of fetal dynamic cardiac short-axis
images (2.7 ± 0.8 pixels) was similar to adult values
(2.6–3.3 pixels) using DUS gating [8, 9]. The observa-
tion of lower end-diastolic EB can be explained by re-
duced radial, tangential, and longitudinal myocardial
velocities during diastole, and is in agreement to find-
ings of DUS gated CMR in adults [8]. Both the high
image quality and little impact of motion blurring
with clear differentiation between myocardium and
lumen indicate high gating quality. In this work a
temporal resolution of 14–24 ms was used to capture
fetal cardiac wall motion to assess fetal cardiac func-
tion. In prior work by Haris et al. and Roy et al. fetal
cardiac function was assessed with a temporal reso-
lution ranging from 31 to 40 ms [14, 19]. As the
temporal resolution was even lower in this study, we
assume it is sufficient to capture fetal cardiac wall
Fig. 5 Left Ventricular Myocardial Wall Motion and Endocardial Blurring. Left ventricular (LV) wall motion and endocardial blurring for DUS-gated fetal
CMR. Mid-ventricular short-axis and 4-chamber images in end-diastole are shown in a) and c) with the solid line marking the plane for the corresponding
projection of myocardial wall motion over the cardiac cycle as shown in b) and d) with the endocardial border marked orange. Average endocardial
blurring of LV wall motion over the entire cardiac cycle is shown in e) and was sensitive to cardiac phases in terms of reduced EB during diastole
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motion. However, it must be mentioned that there is
only limited experience in dynamic fetal CMR and
thus no established reference CMR protocols so far.
In the current study dynamic fetal CMR and morpho-
logical analysis was focused on the 4-chamber view as
this is commonly used for evaluation of fetal cardiac
pathology, with sensitivity and specificity of 88% and
96%, respectively [20, 21]. The possibility to synchronize
the CMR data acquisition to the fetal heart beat offers
high image quality for visualizing small structures. In the
current study the atrial septum was visualized in all
cases, whereas a previous study using non-gated bSSFP
sequences only managed this in one third of the fetuses
[22]. Also, the foramen ovale was visualized in all fetuses
in the current study but varied widely in previous stud-
ies, between 6% using real-time cine imaging [23] and
95% using non-gated bSSFP images [24]. Myocardial
wall thickness was comparable to recently published
data using metric optimized gating (MOG) (2.6 ±
0.3 mm), self-gating (2.7 ± 0.3 mm) and real time im-
aging (3.0 ± 0.4 mm) [14]. The slightly higher values in
our study (3.4 ± 0.5 mm) may be due to methodological
differences as measurements in our study were assessed
from the midcardial septum instead from the postero-
lateral LV wall. In addition, the assessed LV stroke vol-
umes of 1.9 (± 0.8) ml in our study subjects with
gestational ages ranging from 30 to 39 weeks are com-
parable with reported ultrasound data of 2.1 ml (95% CI
1.27, 3.4) for fetuses of 34 weeks gestational age [25].
The mean EDV of 2.8 (± 1.2) ml calculated for the fe-
tuses in this study are also very similar to the EDV of a
large fetal ultrasound study [26]. Furthermore, the rela-
tively high standard deviation of assessed EDV in this
study is in concordance of the wide range of EDV be-
tween 30 and 39 weeks of gestation, approximately ran-
ging form 0.5–5.5 ml [26].
Until now fetal CMR has been limited due to technical
challenges [4], mainly the lack of a fetal ECG for gating.
As a consequence of unavailable direct fetal cardiac gat-
ing so far, dynamic fetal CMR was dependent on compli-
cated post-processing techniques only available in a few
centers. A major innovation was the introduction of
MOG [27]. Image data is continuously acquired without
gating and iteratively reconstructed at varying heart
rates. A gating signal is determined retrospectively by
optimizing an image metric [19, 28]. Several studies
proved feasibility of this technique performing phase-
contrast angiography for the assessment of fetal blood
flow characteristics including 3 T application [29–32]. A
clear limitation of this method is that MOG is prone to
heart rate variability, namely the inability to adjust the
gating signal to varying heart frequencies. Therefore, the
Fig. 6 Bland Altman Plots for Inter-Observer Agreement. Bland Altman plots for inter-observer agreement of left ventricular a) end-diastolic volume
(EDV), b) end-systolic volume (ESV), c) stroke volume (SV) and d) ejection fraction (EF). Continues black lines represent bias and dashed lines indicate
95% limits of agreement
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modeled fetal heart rates may be a potential source of
error when performing quantitative measurements. This
aspect has to be emphasized considering the broad vari-
ation of fetal heart rate also in the healthy fetus, with re-
ported frequencies between 138 and 175 bpm during
CMR examination [27]. Post-processing of the acquired
MOG images can also be extensive, and requires special-
ized software. Depending on the processing algorithm,
reconstruction times from 10 min up to 2 h for a single
slice were reported [28]. Although MOG can produce
high-quality diagnostic images the post-processing times
illustrate the limitation of all such techniques for wide-
spread implementation in clinical routine.
Another approach to realize fetal cardiac gating is the
self-gating method. This technique estimates a periodic
gating signal by processing acquired k-space data [33]. A
fully sampled k-space data set is then fed into a recon-
struction algorithm [34]. The self-gating method identi-
fies characteristic patterns of the cardiac cycle (e.g.
contraction) that are used as reference for the following
cardiac cycles [35]. Studies in fetal sheep revealed satis-
factory image quality that was only slightly inferior to
that of pulse-wave triggered images [36]. Feasibility of
high-quality functional imaging of small sized hearts
using self-gating was demonstrated in rats at 3 T [37].
Only recently self-gated CMR of the human fetus using
parallel imaging and sparse sampling modifications
(iGRASP) to accelerate image acquisition was success-
fully performed. The study demonstrated equal results
for quantitative and qualitative measures comparing self-
gating and MOG, however with improved image quality
[14]. Albeit reconstruction now can be performed in a
matter of minutes the technique is dependent on spe-
cialized software.
Although MOG and self-gating methods can provide
high-resolution images, the post-processing steps are
time-consuming and preclude rapid reconstruction; con-
sequently, there is little opportunity to review data qual-
ity during the examination or adapt imaging planes in
case of fetal movement. Whereas fetal echocardiography
represents a fast, non-invasive and widely available diag-
nostic tool allowing for real-time imaging with high
spatial resolution [38], improved fetal CMR with gated
acquisition may be crucial in selected cases for enhanced
diagnostic quality.
A limitation of the current study is the focus on 4-
chamber and short-axis views only. However, this initial
step is sufficient for improved utility of fetal CMR im-
aging as the 4-chamber view is commonly used for diag-
nosis of fetal cardiac malformation. Future studies have
to evaluate DUS gated fetal CMR imaging for other im-
aging planes and also other anatomic structures, also po-
tentially including reference-imaging standards for
comparison. Finally, fetal movement during CMR may
require re-positioning of the DUS transducer with pro-
longed examination times, however already indicated to
not be a major issue. Moreover, fetal movement or
uterus contractions may lead to disrupted gating signals.
A potential enhancement of the DUS gating method
would be a wider ultrasound field, covering a larger por-
tion of the maternal abdomen to prevent repositioning
of the DUS transducer in case of major fetal movement.
Finally, there was only a small study population that was
divided over 3 centers using different scan parameters.
For example, the protocols differed in the coverage of
heart phases (30 phases to 20 phases), which could have
affected EB analysis.
Conclusion
High-quality dynamic fetal CMR was successfully per-
formed for the first time in human fetuses using a newly
developed DUS device for direct cardiac gating. This
technique has high potential to improve the utility of
fetal CMR in the evaluation of congenital pathologies.
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